Supplemental Tables/Figures

Slides:

Advertisements

Similar presentations

Supplemental Figure 1 A No. at risk T T T

Advertisements

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Single-chain antibodies for the conformation-specific blockade of activated platelet integrin  IIb  3 designed by subtractive selection from naïve human.

Figure 14-1 Molecular Biology of the Cell (© Garland Science 2008)

Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,

Synergistic antitumor effect of anti-CD40/CpG and 14

Figures & Tables from the textbook.

A B C Supplementary Figure 1 Group 1 Group 2 Group 3 #1 #2 #3 #4 #5 #6

Tax fingerprint in adult T-cell leukemia

Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection by Shokrollah Elahi, Toshiro Niki, Mitsuomi Hirashima,

Supplemental Fig 2. Wu et al

[68Ga]Pentixafor PET imaging of MM xenografts Real‐time PCR analysis of cxcr4 transcript expression levels in HeLa (negative control) and in MM cell lines.

Finding and Killing the CRABs of Pancreatic Cancer

Chemokines and chemokine receptors: here, there, and everywhere

H31m1-PDL1 cells form progressively growing tumors in WT mice.

Fig. 8. mRIPO elicits neutrophil influx followed by DC and T cell infiltration into tumors. mRIPO elicits neutrophil influx followed by DC and T cell infiltration.

SUPPLEMENTAL TABLE 1. Cell cycle profiles of HeLa cells treated

Figure 2 The frequency of helper T cells (Th) within CD4+ population and TCRγδ within CD3+ cells is affected by FTY and DMF treatment The frequency of.

rSema4A induces iTreg cells in CD4+ T cell cultures.

Expression of PD‐1 on PBMC and malignant exudate T cells

Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.

FGF-2 signaling mediates expansion of HSPCs

High frequency and unique tumor‐initiating cells (TICs) in Pten/p53‐deficient mice Flow cytometry profiles of indicated tumors with the CD24 and CD49f.

Refer to word document for this table

Figure 2 CD4+ and CD8+ T cells accumulate in the CSF in GABAB receptor antibody–associated LE CD4+ and CD8+ T cells accumulate in the CSF in GABAB receptor.

(apoptotic + necrotic)

Figure 1 Schematic overview of flow cytometry Schematic overview on the analysis of peripheral immune cells by flow cytometry. Schematic overview of flow.

The PbGAPDH G6 fragment interacts with recombinant CD68.

Figure Overview.

Figure Overview.

Binding competition between B2′B3 and B3 fragments of TcdB.

Mutant Alanine Position

A novel CXCR4 antagonist IgG1 antibody (PF ) for the treatment of hematologic malignancies by Shu-Hui Liu, Yin Gu, Bernadette Pascual, Zhengming.

Supplemental Figure 1A SMM Patient #1 MP-CTL % CD3+ CD8+ T Cells

Figure 1 B cells and plasma cells accumulate in the CSF in GABAB receptor antibody–associated LE B cells and plasma cells accumulate in the CSF in GABAB.

Figure 2 Induced deletion of CXCR2 on oligodendrocyte lineage cells after tamoxifen injection in Cxcr2-cKO mice Induced deletion of CXCR2 on oligodendrocyte.

Development of human T-cell subsets in NSG hL-7xhIL-15 humanized mice.

Actin assembly in response to thrombin.

Hematopoietic potential of HEP from patient-specific iPSC may be reduced. Hematopoietic potential of HEP from patient-specific iPSC may be reduced. (A)

Silencing Ifngr1 in the CMT167 line confers decreased response to IFNγ in vitro and in vivo. Silencing Ifngr1 in the CMT167 line confers decreased response.

Highly related T9 and T3 sarcoma cells show distinct tumor growth patterns but similar PD-L1 expression kinetics in vivo. Highly related T9 and T3 sarcoma.

Increased reconstitution of human NK cells in NSG hIL-7xhIL-15 humanized mice. Increased reconstitution of human NK cells in NSG hIL-7xhIL-15 humanized.

Comparison of conventional NSG and hIL-7 expressing NSG humanized mice

Effects of DWJM on UCB CD34+-derived cell subsets.

SYK activity is required for anti-IgM–induced CD86 expression.

B cell development in wild-type and Syk-AQL mice.

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Exosome-mediated inhibition of T cells is reversible.

Figure 2. Immunophenotypic characteristics of Gal-4-treated monocytes

Spontaneous and strong Tfh cell but not Tfr cell development in IL-2 KO mice. Spontaneous and strong Tfh cell but not Tfr cell development in IL-2 KO mice.

Loss of Tfh and GC B cells in 2KO-Bcl6TC mice.

Overexpression of IL-27 upregulates expression of multiple IR by T cells in vivo. Overexpression of IL-27 upregulates expression of multiple IR by T cells.

BMS blocks functional responses in primary immune cells driven by IFNα

CD8 T cells play a critical role in responses of TILs due to BRAF inhibition. CD8 T cells play a critical role in responses of TILs due to BRAF inhibition.

Increased CCL5 expression, infiltration of Treg cells, and apoptosis of CD8+ T cells in human colorectal tissues. Increased CCL5 expression, infiltration.

Reduced tumor growth in CCR5-deficient mice is associated with perturbed killing ability of Treg cells. Reduced tumor growth in CCR5-deficient mice is.

ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells, and NK cells. ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells,

Dual blockade of PD-1 and CTLA-4 directly activates CD4+Foxp3− cells in the absence of CD8+ or CD4+Foxp3+ cells. Dual blockade of PD-1 and CTLA-4 directly.

DAC treatment alters immune cell composition and enhances cytokine production in the peritoneal lavage. DAC treatment alters immune cell composition and.

Mice with a B cell–specific deletion of Ets1 have increased memory phenotype B cells but no increase in switching to IgG1. Mice with a B cell–specific.

Anti-CD40 activates TAMs and recruits inflammatory monocytes.

IL35 regulation of tumor growth is accompanied by suppression of CD4+ effector T-cell activity and expansion of Tregs. IL35 regulation of tumor growth.

Mice with a B cell–specific deletion of Ets1 do not have increased CD4+ T cell activation. Mice with a B cell–specific deletion of Ets1 do not have increased.

Fig. 3. Association between peak CTL019 expansion and response.

CD36 expression in tissue adjacent and distal to the tumor.

AMG 176 exhibits robust single-agent activity in vivo.

EC-derived SP cells are targeted by CD30.CAR T cells.

Surface expression of chemokine receptors on M

Presentation transcript:

Supplemental Tables/Figures Liu et al. manuscript Supplemental Tables/Figures

Supplemental Table 1: Cell Lines CXCR4 % positive ± SEM Ramos 99 ± 1.7 OPM-2 71 ± 1.6 MV4-11 80 ± 9.0 TF-1 3 ± 0.5 PF-06747143 Binding to hematological tumor cell lines by flow cytometry

Supplemental Figure 1 A. CHO-Parental B. CHO-hCXCR4

Supplemental Figure 2 A B C D E Ramos (PF-06747143) Ramos (CD184- 12G5 clone) A B OPM-2 (PF-06747143) MV4-11 (PF-06747143) C D E TF-1 (PF-06747143)

Supplemental Figure 3

Supplemental Figure 4

Supplemental Figure 5